FinancialPress releases

Q2 Interim Report October – December 2023

By February 22, 2024 No Comments

Related Posts

Press releases

Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group

Hamlet Biopharma
Hamlet BiopharmaApril 18, 2024
Press releases

Alpha1H to be the first asset for the commercial collaboration

Hamlet Biopharma
Hamlet BiopharmaApril 11, 2024
Press releases

Immune responses in patients treated with Alpha1H – results published in the journal Cancer Medicine

Hamlet Biopharma
Hamlet BiopharmaApril 3, 2024
Hamlet Biopharma

Author Hamlet Biopharma

More posts by Hamlet Biopharma

Hamlet Pharma AB

BMC D10
Klinikgatan 32
SE-222 42 Lund, Sweden
+46 40 12 25 00
info@hamletpharma.com

Swedish